3K Bicas Co., Ltd. is a specialized company that builds big data in the medical field and develops an artificial intelligence platform by analyzing and processing structured/unstructured metadata based on international standard XML.
Mission
3KBICAS strives to improve human health and a happy life through IT technology.
Vision
Start
Cerebrovascular disease solution based on prediction
Jump
A leap forward as an AI company specializing in brain diseases
(cerebrovascular diseases, Alzheimer's, Parkinson's, brain tumors, etc.)
Goal
Aim for socially responsible management that can resolve medical inequality
Team Profile
Dongsoo Song
CEO & CTO
Consulting, Analysis Design
Computer Officer, Army Military Investigation
Korea Computer Co., Ltd. INEK Co., Ltd.
Hongik University Computer Science
Hyunho Ahn
CEO
Former Samsung Lions general manager
Former Samsung Sports Team
Kyungpook National University
Juhyung Lee
President/CMO
Vice President at 3K Soft Co., Ltd.
CEO of GIO Co., Ltd.
Hallym University
Dongsoo Song
CEO & CTO
Consulting, Analysis Design
Computer Officer, Army Military Investigation
Korea Computer Co., Ltd. INEK Co., Ltd.
Hongik University Computer Science
Gyeonghee Bea
Senior Researcher
AI video information analysis / construction development
Development of patient safety nursing system and electronic consent form
Development of an XML-based research data integrated management system at Seoul National University System Immunology Research Institute
Pusan National University Architectural Engineering
Junpil Kim
Research Engineer
AI visual / thermal image analysis / construction / management system development
AIoT analysis / construction and integrated control system development
Kwangwoon University Software Engineering
Jaehak Lee
Research Engineer
Server Management
Worked at Okelmi
Graduated from Wirye Information Industrial High School
Minhyuk Kim
Assistant Researcher
Development of automatic video analysis / classification system
AI video analysis / development
Suncheon National University Computer Engineering
Junghwan Hyun
Assistant Researcher
Development of AI natural language processing analysis / classification system
AI video analysis / development
Kangwon National University Mathematics
Youngseok Seo
Assistant Researcher
Development of AI natural language processing analysis / classification system
AI video analysis / development
Bucheon University Department of Electronics
Jiye Song
Assistant Researcher
UI/UX Designer, Front-end Developer
S_Lab Service System User Interface(UI) Development
Graduated from Seoul Finance High School
Chulho Kim
Prof. / Outside Director
PhD in Neuroscience from Hallym University College of Medicine
Department of Neurology, Hallym University Chuncheon Sacred Heart Hospital
Adjunct Professor of Artificial Intelligence Convergence
Youngtak Kim
Research Professor
Senior Researcher, NeuroTx Co., Ltd.
Development of an intelligent clinical decision support system for brain damaged patients
Development of real-time patient smart monitoring system
Non-invasive BCI integrated brain cognitive computing SW platform technology development
Korea University College of Informatics Brain Engineering
Dongju Kim
Professor
PhD in Biomedical Engineering from Cambridge University, UK
Brain Engineering Department, College of Informatics, Korea University
Adjunct Professor of Neurology and Artificial Intelligence Studies
Sangwon Seo
Dean
PhD from Texas State University, USA
Dean of Hallym University College of Medicine
Brain neuroscientist
Sanghyung Lee
Professor
Doctor of Neurosurgery at Seoul National University College of Medicine
Professor of Medicine at Seoul National University College of Medicine (Neurosurgery, Department of Medical Device Industry)
Seoul National University Boramae Hospital Neurosurgery
Jundong Park
Professor
PhD in Pediatrics from Seoul National University College of Medicine
Chief of Pediatric Emergency Department at Seoul National University Hospital
Director of Seoul National University Institute of Immunology
Myunghwa Kim
Executive Advisor
PhD in Medicinal Chemistry, University of Mainz, Germany
Former Acting Director/CSO of the Pan-Ministry New Drug Development Division
Former CEO of CURACLE Co., Ltd.
Daesoon Son
Professor
Former Clinical Research Team Leader, Life Science Research Institute, Samsung Seoul Hospital
Former Director of Research Operations, Genome Research Institute, Samsung Seoul Hospital
Director of Hallym University Realistic Media Contents ICC Center
Assistant Professor, Data Science Convergence School, Hallym University
PhD in Statistics from Korea University
Hyunwoo Kim
Doctor
Doctor of Neuroscience, Yonsei University Medical School
Director of System Immunology Research Institute, Seoul National University
Former Department of Neurology, Yonsei University Health System
Dongju Kim
Professor
PhD in Biomedical Engineering from Cambridge University, UK
Brain Engineering Department, College of Informatics, Korea University
Adjunct Professor of Neurology and Artificial Intelligence Studies
Hyuncheol Kim
Professor
PhD in Computer and Information Science, University of Florida, Gainesville, USA
Head Professor, Artificial Intelligence Convergence Major, College of Information, Korea University
S_Lab - Establishment of Service System(On-Premise)
04
MAPIS Trademark Registration
01
Development of Generative AI Solution(S_Lab)
2023
06
Joint research on Hallym University industry-academia cooperation technology development, advancement of recognition performance of thermal image/video data
04
Hallym University - 3K Bicas Co., Ltd. signed a business agreement for establishment of an industry-academia cooperation system and mutual development.
03
Selected as TIPS project by Ministry of SMEs and Startups
2022
11
Patent application for management of high-risk area objects based on deep neural network
10
Signed MOU for joint research and development of ‘intelligent thermal imaging IP camera system’ with EOC Co., Ltd.
06
Attracted investment from MAGNA Investment Co., Ltd. for ‘MAGNA Rizing Star2 Fund’(KRW 200 Million)
02
Seoul National University System Immunology Research Institute MOU for development and construction of XML-based laboratory operation system
01
Registered patent for XML-based medical institution database integrated management system
2021
09
Registered patent for prediction the potential transformation into a Hemorrhagic Stroke
05
AMEXG Metaverse Development Consulting Agreement Signed
2020
12
Attracted crowdfunding investment (IBK Securities Co. Ltd., KRW 93 Million) Applied for 1 blockchain and XML-based patent
11
Certified as a venture business
10
Development of online manual management system
07
Acquired certification as the best company in technology evaluation (TI-3)
03
Applied for 2 medical-related patents
2019
11
Signed a contract to build an AutoXML-based research data integrated management system with Seoul National University
10
Signed a research project performance contract with Hallym University Chuncheon Sacred Heart Hospital to develop a deep learning algorithm for predicting cerebral infarction hemorrhagic transformation
07
Development of a blockchain-based online smart 10,000 bachelor’s degree membership system for the Republic of Korea Army Bachelor’s Officers’ Alumni Association
05
Joined as a member of the Ministry of Land, Infrastructure and Transport's Smart City Convergence Alliance
01
Establishment of a corporate research center (information processing field)
2018
11
Establishment of 3KBICAS Co., Ltd.
Company Roadmap
2023
07Completed development of MAPIS, a cerebral infarction prediction algorithm
08Launch of cerebral infarction prediction diagnosis program
Application for certification from the Ministry of Food and Drug Safety(MFDS)
Ministry of Food and Drug Safety clinical trial approval
2024
07Development of the Cerebral Infarction Prediction Diagnosis Program
Started development of AI-based brain tumor and Alzheimer's diagnosis program (data collection)
Acquired new health technology (NET) hosted by the Ministry of Health and Welfare
Obtained the MDFS medical device management standards (GMP) - cerebral infarction prediction diagnosis
Application for approval from FDA, CE, etc.
2025
Development of Brain Tumor and Alzheimer's Disease Diagnosis Programs
Acquired the MDFS medical device management standards (GMP) - Brain tumor and Alzheimer's diagnosis
Cerebral infarction clinical trial completed
Application for approval from FDA, CE, etc.
Health insurance fee applies
Supply to domestic and international hospitals
2026
Global business development through overseas local corporations
Continuous expansion of major global licenses
Accelerating cooperation with global medical device companies